Big pharmaceutical companies such as Bristol Myers Squibb, Merck, and Johnson & Johnson face a looming threat that will put tens of billions of dollars in sales at risk between now and 2030, as blockbuster drugs will tumble off a so-called ‘patent cliff’.
A new study links increased use of acetaminophen (paracetamol) during pregnancy – particularly in the second trimester – to modest but noticeable increases in problems with attention and behavior in 2-, 3- and 4-year-olds.
A French appeals court has ordered pharmaceutical firm Servier to pay more than $460 million in damages over a scandal involving a diabetes drug linked to hundreds of deaths.
A court document obtained by POLITICO shows that Pfizer, together with its partner BioNTech, opened legal proceedings against the Hungarian government in January this year over COVID-19 vaccine deliveries.
Australian GPs are prescribing more antipsychotic drugs to children and adolescents for unapproved uses, according to a new study by University of Adelaide researchers.
Texas is suing Pfizer over claims the drugmaker made about its Covid shot. The state's Attorney General Ken Paxton has accused the pharma giant of misrepresenting the vaccine’s efficacy.
Research led by the Karolinska Institute in Sweden has found an increased risk of cardiovascular disease associated with long-term ADHD medication use.
Johnson & Johnson, Merck and Other Pharma Firms Prepare to Lose Billions from Blockbuster Drugs